Alnylam Pharmaceuticals Reports Second Quarter 2012 Financial Results
16:00 EDT 6 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Alnylam
Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, today reported its consolidated financial results for the
second quarter 2012, and company highlights.
“This was an exceptional...
Other Sources for this Article
Alnylam Pharmaceuticals, Inc.
Cynthia Clayton, 617-551-8207
Vice
President, Investor Relations and
Corporate Communications
or
Michael
Mason, 617-551-8327
Vice President, Finance and Treasurer
More From BioPortfolio on "Alnylam Pharmaceuticals Reports Second Quarter 2012 Financial Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
